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Plasma refill activity and substrate levels in patients with the
nephrotic syndrome. E. J. Dorhout Mees, G. G. Geyskes, J. C.
Roos, and P. Boer. Dept of Nephrology and Hypertension, Uni-
versity Hospital, Utrecht, The Netherlands. The traditional ex-
planation for the pathogenesis of edema in the nephrotic syn-
drome (NS) is that decreased blood volume induces active salt
and water retention by the kidney. This is mediated also by acti-
vation of the renin-angiotensin-aldosterone system. Previous
work from our laboratory showed, however, that in many pa-
tients with NS and "minimal lesion," blood volume is high and
PRA normal to low. As an alternative explanation, an impair-
ment of glomerular permeability was suggested, which might al-
so explain the low filtration fraction. Medina and others reported
low plasma renin substrate (PRS) in some patients with NS, sug-
gesting this might be related to the failure of plasma All and al-
dosterone levels to rise. We, therefore, analyzed this question
further. Results. Normal PRS concentrations were 870 95
moles/ml for men and 725 80 for women on normal salt intake
and did not change after salt restriction. In 28 patients with the
NS from various causes, PRS was found decreased in 2 and ele-
vated in 13. There was no relation with PRA levels or amount of
protein loss. In 10 patients with minimal lesions, PRS was also
measured after remission. A further rise was observed in 4 and
decrease in I. Among the 7 subjects who were still on predni-
sone, PRS rose in 4 and remained constant in 3. One patient was
followed up while she developed a NS, as well as during recov-
ery. At the height of edema formation, plasma volume had
dropped from 3.0 to 1.7 liters, and PRA increased a 100-fold. The
filtration fraction (FF) was found to be high (0.39) in contrast to
the group of patients described previously. Conclusions. (1) PRS
is variable in patients with the NS, but elevated on the average,
and bears no relation to PRA or the amount of protein loss. It
cannot be responsible for the relatively low PRA levels. (2) Some
patients with the NS develop a drop in plasma volume. In that
case, the other parameters are different from those with normal
to high plasma volumes: PRA, aldosterone, and FF are elevated,
blood pressure is low, but PRS does not behave differently.
In situ formation of glomerular immune complex aggregates in
passive serum sickness glomerulopathy. G. J. Fleuren, J. Grond,
and P. J. Hoedemaeker. Department of Pathology, University of
Groningen, Groningen, The Netherlands. The development of
the serum sickness model of experimental glomerulonephritis in
the early 1960's provided evidence for glomerular deposition of
circulating immune complexes as the pathogenetic mechanism of
immune complex glomerulonephritis. Especially small immune
complexes were thought to transit across the GBM and to local-
ize at the subepithelial side of the GBM. In experiments of pas-
sive serum sickness, however, intravenous injection of pre-
formed immune complexes of different size and composition
never resulted in a subepithelial localization along the GBM. Be-
cause of this apparent discrepancy and because it was shown
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that in heterologous and autologous immune complex glomerulo-
nephritis the glomerular immune complexes were formed in situ.
a study was performed to investigate whether such a patho-
genetic mechanism could also operate in a passive serum sick-
ness model of glomerulonephntis. In an unilateral perfusion sys-
tem, rat kidneys were perfused alternately with PBS, BSA, PBS.
and anti-BSA. This sequence was repeated four times, where-
after the perfused kidney was reconnected to the circulation dur-
ing time intervals varying from 10 mm until 3 days. The perfused
kidney showed a granular deposition of anti-BSA and BSA along
the GBM at all moments studied. Electron microscopy showed
that these deposits were localized subepithelially. Control exper-
iments in which unilateral perfusion was performed with BSA
alone, anti-BSA alone, preformed immune complexes, or alter-
nately with BSA and normal rabbit IgG never resulted in granu-
lar deposition along the GBM. In perfusion experiments in which
the antigen used was known to bind to the GBM, like lysozyme,
an alternating perfusion with antigen and antibody likewise re-
sulted in a subepithelial localization of immune complexes.
These results indicate that alternating perfusion with antigen and
antibody can result in subepithelial glomerular deposition of im-
mune complexes which apparently are formed locally. The
mechanism of in situ formation of glomerular immune complexes
might also be important in human glomerulopathy with epimem-
branous deposition of immune aggregates with involvement of
either autologous antigens oir heterologous antigens.
Intraluminal dilatation of renal artery stenosis. G. G. Geyskes,
C. B. A. J. Puylaert, H. Y. Oei, andi. H. B. Boomsrna. Univer-
sity Hospital, Utrecht, The Netherlands. In 13 patients with hy-
pertension and renal artery stenosis, the stenosis was dilated by
an intraarterial balloon-catheter (Dotter-Gruntzig method) under
local anesthesia. Arteriography directly after the dilatation
showed considerable widening of the stenosed area in all pa-
tients. A complication in one patient was an intramural injection
of contrast that caused an irregular contour of the renal artery.
Six patients had a temporal decrease of their renal function that
lasted only a few days. In 6 patients who had a prolonged transit
time at renography, this marker of renal blood flow improved
after the dilatation. Peripheral PRA decreased in 6 of the 8 pa-
tients in whom this parameter was determined. One patient, a
young woman, became normotensive. In 6 patients, the blood
pressure became normal with the same or less therapy. In 3 pa-
tients, the blood pressure became lower, but they still remained
hypertensive. Three other patients had no antihypertensive re-
sponse. One of them had an even more severe stenosis of the
artery of the contralateral kidney. This patient died some months
later because of myocardial infarction. The dilated artery
showed atherosclerosis without major stenosed areas. Con-
clusion. Dilatation of renal artery stenosis by an intraarterial bal-
loon catheter is a promising treatment for patients with hyper-
tension and renal artery stenosis. It is a rapid procedure with
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only local anesthesia. Complications are so far minor. The anti-
hypertensive effect in this group of patients, selected on arteri-
ography only, seems comparable to major surgical procedures.
Renin-angiotensin system and blood volume in patients with
dialysis-resistant hypertension. F. T. M. Huysmans, T. Thien,
and R. A. P. Koene. University Hospital, Department of Ne-
phrology, Nijinegen, The Netherlands. Relationships between
PRA, blood pressure response to saralasin (z% MAP,ar) and
blood volume (BV) were studied in 11 dialysis patients with hy-
pertension that could not be controlled by ultrafiltration, and in 4
dialysis patients with normal blood pressure. All anti-
hypertensive drugs were discontinued at least 1 week prior to the
study. A hypotensive response to saralasin was recorded in 9 of
the 11 hypertensive patients (% MAP,ar, more than —10%;
mean, —27.0 [sEM] 3.9). Mean PRA in this group was highest
(1251 420 ng/10 ml . 3 hr), and mean BY was lowest (88.8
3.9%) as compared to the nonresponders. Despite the decreases
in blood pressure, heart rates did not increase. In 4 normotensive
patients, mean % MAP,r was —1.7 3.0%, mean PRA was 197
103 ngIlO ml 3 hr, and mean BV was 96.7 3.7%. Two
hypertensive patients showed no blood pressure response to sa-
ralasin (% MAPSar, 0 and —4.3%). These two patients had a low
PRA (highest value, 132 ngIlO ml 3 hr) and blood volumes of
94.1 and 97.5%. In 6 hypertensive responders to saralasin, the
study was repeated 10 days later after volume loading: mean
body-weight increase was 6.9%, BY increased to 107.5 4.0%,
PRA decreased to 330 87 ng/10 ml 3 hr, and MAP5ar
decreased to —9.2 4.2%. Two of these patients with the high-
est BV even showed no hypotensive response to saralasin under
these conditions. X% MAPSar correlated significantly with PRA
prior to the 21 saralasin infusions (r =
—0.73). During the 13
saralasin infusions, which resulted in a hypotensive response,
PRA increased. In 5 hypertensive responders to saralasin, blood
pressure became normal after bilateral nephtectomy. The results
show that the renin-angiotensin system in dialysis patients reacts
to volume changes and angiotensin II blockade as in nondialysis
patients. The blood pressure response to angiotensin II blockade
is comparable to that in nondialysis patients. In the majority of
hypertensive patients, the renin-angiotensin system plays an im-
portant role in sustaining high blood pressure, if blood volume is
low or normal.
Effect of prostaglandin (PG) Inhibition on sodium excretion in
the conscious rat. N. Lameire, V. Vanderbiesen, and M. A. Wa-
terloos. Division of Nephrology, Department of Medicine, Uni-
versity Hospital, Gent, Belgium. Studies were performed to de-
termine the role of decreased endogenous release of renal prosta-
glandins (PG) on UNY during expansion of the ECF volume in
the conscious rat. Meclofenamate (M) or indomethacin (I) (5 mg/
kg) was given after 5% body-weight expansion with either isoton-
ic Ringer's solution (group A) or 2.5% glucose (group B) and
compared to similar groups of rats given a placebo (P) injection.
In addition, the drugs were given also to a third group (C) of
hydropenic rats before a 10% body-weight expansion with iso-
tonic Ringer's solution. UNaV was lower after M in group A con-
comitantly with a fall in PAH clearance and an unchanged GFR.
I or P did not result in changes in renal function or UV in this
setting. UNaY was similar in control and PG-inhibited animals of
group B. In both groups A and B, urinary PGE2 excretion (UPGEZ)
after M and I dropped approximately 50% and remained un-
changed after P. In group C, both I and M before Ringer loading
prevented the rise in GFR, PAH clearance and UPGES excretion
normally associated with a massive volume expansion (yE), as
compared to the P-treated animals. However, the rise in FENa
was very similar in the P-treated animals compared to the M or I
injected animals (LFENa was 6.67 1.33% in P, 5.85 1.13% ifl
M, and 6.03 1.04% in I) (P> 0.05). These data do not confirm
the hypothesis that enhanced prostaglandin release is an impor-
tant determinant of the natriuresis during acute YE.
Renal function study in 30 patients on long-term lithium thera-
py. E. J. L. Prins, A. Annema, S. Me(jer, J. W. B. M. van Ber-
kest,jn, L. C. W. Dols, and A. J. M. Donker. Renal Unit and
Department of Biological Psychiatry, State University Gronin-
gen, The Netherlands. Recent studies suggest that after 2 years
of administration lithium exerts irreversible, nephrotoxic side-
effects in about 20% of the patients. This prompted us to investi-
gate the renal function in 30 nonselected patients on long-term
lithium carbonate therapy (mean duration, 39 3.6 months;
range, 4 to 76 months). None of the patients appeared to have
been suffering from a lithium intoxication. During lithium car-
bonate therapy (mean lithium concentration, 0.8 0.05), mean
urinary concentration (± sEM) after 22 hours of water depriva-
tion (= Uüam) and 10 sg of desamino-cys1-(D-Arg8)-vasopressin
diacetate administered intranasally amounted to 854 22 mOs-
moles/kg H20 (normal value, 1089 mOsmoles/kg H20). The low-
est values were 524 and 625 mOsmoles/kg H20, respectively.
Mean GFR was 101 4 mllmin; mean ERPF, 360 18 mllmin;
and mean minimal urinary pH after ammonium chloride loading,
4.95 0.06. In 8 out of 30 patients, there was polyuria (urine
volume, > 3000 ml/25 hr). In these 8 patients, we measured 778
51 mOsmoles/kg H20, 113 6 mI/mm, 415 33 mllmin, and
4.99 0.08, respectively. Serum levels of beta-2-microglobulin
and lysozyme, and the urinary excretion of these substances
were normal in all patients. As it has been shown in animal stud-
ies that lithium increases urinary POE2 excretion, 50 mg of indo-
methacin orally was administered in 19 out of 30 patients at the
end of the urinary concentration test. Uo,m rose significantly
from 833 33 to 937 33 mOsmoles/kg H20. In 10 normal vol-
unteers, an increase from 1089 to 1195 mOsmoles/kg H20 was
noticed during the same procedure. We conclude that, given
proper dosage (three times per day) and surveillance (serum lith-
ium concentration, between 0.8 and 1.2 mmoles/liter 12 hours
after the last dose), long-term treatment with lithium carbonate
will not cause gross disturbances in renal function, including
maximal urinary concentration ability. Second, in normal man
and in patients on lithium carbonate therapy indomathacin in-
creases Uosm; however, a slight difference between normals and
patients still can be observed.
Effects of diazoxide on nephron function and on intrarenal ves-
sels studied in the isolated rat kidney. J. F. G. Slegers. Depart-
ment of Physiology, University of Nijmegen, Nijmegen, The
Netherlands. The effect of diazoxide on renal tubular function
and on renal vasculature was studied using the isolated cell-free
perfused rat kidney. For the sake of comparison, the structurally
related compound hydrochlorothiazide was also incorporated in
this study. In kidneys of normotensive rats, no statistically sig-
nificant influence of diazoxide (100 jsg/ml of perfusion fluid)
could be detected on diurese, GFR, and sodium or potassium
excretion rates, whereas hydrochlorothiazide (20 jsg/ml) in-
creased all four parameters significantly (P < 0.001) as compared
with the controls. If the perfusate contained diazoxide per-
manently and then hydrochlorothiazide was added, the same in-
crease in the parameters was observed, indicating that diazox-
ide, despite the structural similarity, does not compete for the
same receptor sites as used by hydrochlorothiazide. Diazoxide
was also studied on kidneys of hypertensive rats of four different
ages; 10, 20, 30, and 45 weeks old. Again no statistically signifi-
cant influence of diazoxide on water or sodium handling could be
detected in either of the age groups. Additional experiments with
diazoxide were performed on the isotonic water and salt trans-
port process of the isolated gallbladder and on the sodium trans-
port process of the isolated perfused main duct of the rabbit sub-
maxillary gland. In both cases, diazoxide failed to demonstrate
any inhibition or promotion of the sodium transport process. To
study the effect of diazoxide on renal vasculature, first we had to
induce vasoconstriction because the isolated kidney is vasodi-
lated. Barium in low concentrations (0.1 to 1.0 mmoles) showed
to be a potent vasoconstnctor as reflected by the strong increase
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in perfusion pressure. Barium-induced contracture could be in-
hibited by diazoxide dose dependently. The onset of inhibition is
fast, completely reversible, and noncompetitive. Hydro-
chlorothiazide had no effect on the barium contracture. Vaso-
constriction induced by norepinephrine (0.5 rgIml) could also be
inhibited by diazoxide. Vasoconstriction generated by depolari-
zation of the smooth muscle cell membrane, however, did not
react on diazoxide. Depolarization was induced by potassium (40
mmoles) and resulted in a mean increase in perfusion pressure of
136 mm Hg. Diazoxide (100 sg/ml) had no effect on this kalium
contracture but verapamil inhibited the normal response. There-
fore it seems that diazoxide for its action needs normal mem-
brane potential. Furthermore, the noncompetitive interaction
with barium, together with the fact that verapamil could prevent
potassium contracture and diazoxide could not, does not support
the assumption that diazoxide blocks calcium channels in the
smooth muscle cell membranes or reacts with calcium receptors.
Although the exact working mechanism of diazoxide remains un-
known, the results clearly show that intrarenal resistance vessels
do react on diazoxide. The final conclusion may be that the clini-
cal observation of water and salt retention in patients treated
with diazoxide cannot be explained by a direct effect of diazox-
ide on glomerular or tubular function. The water and salt reten-
tion must be a secondary effect caused by the peripheral vascular
reaction of diazoxide in combination with intrarenal vasodilata-
tion.
Renin secretion by the isolated rat kidney. R. Vandongen, K. D.
Strang, M. A. Poessé, C. R. Apap, S. Lustig, P. W. de Leeuw,
H. E. Falke, B. Bakker, and W. H. Birkenhilger. Department of
Internal Medicine, Zuiderziekenhuis, Rotterdam, The Nether-
lands. Isolated rat kidneys were perfused in Situ according to the
method of Vandongen et al (1973) with some minor modulations.
The purpose was to study the relationships between renal vascu-
lar resistance and renin secretion. Experiments and results: (1)
Control studies. During inert observation, renal vascular resis-
tance decreased slightly and renin secretion tended to increase.
Renin was exclusively secreted in an active form, with consid-
erable intraindividuaj and interindividual variations. (2) Effects
of temperature changes. Sudden variations in the temperature of
the perfusate (from 310 to 40° C and back) clearly affected renin
secretion rate and renal vascular resistance. A rise in temper-
ature induced vasodilatation and renin release and the reversed
changes occurred during a drop in temperature. (3) Autoregula-
tion vs. renin secretion. Rapid stepwise increases in perfusion
pressure from 60 to 110 mm Hg revealed a proportional increase
in flow. When pressure was subsequently increased up to 150
mm, in some experiments flow tended to arrive at a plateau (sur-
plus flow was allowed to flow back into the reservoir). In the
plateau phase, renin secretion showed an abrupt decrease. Thus,
a high perfusion pressure together with autoregulatory vaso-
constriction appeared to inhibit renin secretion. (4) Effect of
vasoconstriction. By the addition of procaine to the perfusate, a
marked vasoconstriction could be obtained. Renin secretion de-
creased markedly irrespective of perfusion pressure. (5) Adren-
ergic stimulation. It was reconfirmed that f3-adrenergic stimula-
tion (isoprenaline) induced renin release. By contrast a-adrener-
gic stimulation (phenylephrine) failed to stimulate renin
secretion, but it inhibited the isoprenaline-dependent renin re-
lease. (6) Dissociation of renin-inhibitory from vasoconstrictory
effects ofphenylephrine. Since phenylephrine could induce renin
inhibition by virtue of its vasoconstrictory effect, dihydralazine
was added to the perfusate. Phenylephrine then failed to increase
vascular resistance, but it continued to inhibit isoprenaline-de-
pendent renin release. Conclusion. In the isolated rat kidney, re-
nm secretion is largely dependent on vessel wall tone. In addi-
tion, the a- and /3-adrenergic receptors modulate renin secretion
without intermediary changes in vascular resistance.
Renal function studies in an experimental model of medullary
necrosis in the rat. R. Vanholder, W. Eeckhaut, and N. Lameire.
Division of Nephrology, Department of Medicine, University
Hospital, Ghent, Belgium. Twenty four hours after the intra-
venous injection of bromoethylaminehydrobromide (BEA) in
rats, a uniform medullary necrosis is observed. The present
study investigates the reaction to volume expansion and the pap-
illary plasma flow (PPF) in this model. Renal function studies
were performed in hydropenic and volume-expanded control and
BEA rats. In hydropenic control animals, a diuresis of 9.23 ml!
mm, a GFR of 1.97 mllmin, an urinary osmolality (Uo,m) of 1011
mOsm/kg, and a FENO of 0.18% were obtained. After volume ex-
pansion (10% body wt) the diuresis increased to 20.03 mllmin,
GFR was 3.17 mllmin, U0 was 330 mOsmlkg, and FENa in-
creased to 10.97%. In the BEA-injected animals, values obtained
in hydropenia were: diuresis of 19.95 mI/mm, GFR of 1.16 mI!
mi Uo,m of 469 mOsm/kg, and FENa of 0.37%. The results in
volume-expanded BEA animals were: diuresis of 345 mllmin,
GFR of 2.08 mI/mm, Uosm of 301 mOsmlkg, and FENa of 13.6%.
Mean PPF in hydropenic control animals was 50.65 mlIlOO g pa-
pilla min'; this increased to 66.08 ml!lOO g papilla min after
volume expansion. In BEA rats, PPF was 58.86 ml/lOO g papilla
min1 in hydropenia, and almost no increase was observed when
volume expansion was induced: 61.95 ml/lOO g papilla min1.
Thus, during hydropenia, BEA-induced nephropathy results in a
salt-loosing state and a renal concentrating defect. This corre-
sponds to the clinical disturbances observed in medullary necro-
sis, and makes from this model a useful tool for the study of the
pathophysiology of this disorder. After volume expansion, an
adequate natriuresis and an enhanced water diuresis are ob-
served, in spite of the elimination of the juxtamedullary neph-
rons. PPF in hydropenic BEA rats is significantly higher than it is
in control rats, but it does not increase further with volume ex-
pansion.
Diurnal variation of urinary Pco2: Study of various factors de-
termining the rise of Pco2 in alkaline urine. R. Verberckmoes, J.
Martens, and P. Michielsen. A. Z. Sint-Rafael, Leuven, Bel-
gium. We examined various factors controlling the rise of the
urinary Pco2 in 7 normal volunteers who collected their urine
between 4 and 6 AM. and between 10 and 12 AM. under three
different protocols: (1) after moderate oral supplement of sodium
bicarbonate (7 to 9 g!day); (2) After sodium bicarbonate supple-
mentation as under 1 but with additional oral inorganic phos-
phate (P) supplements (0.35 to 0.45 g of P) ingested between
the first and the second collection period; (3) after a greater oral
sodium bicarbonate supplement (15 to 18 g) and with additional P
supplementation as under 2. In urine obtained between 4 and 6
A.M. with protocols I and 2, the pH was 6.613 0.302, the [P]
was high (36.27 12.48 mM/liter), the [HCO] was low (11.1
8.4 mM/liter), and the Pco2 was 81.0 15.9 mm Hg. In these
samples, we found a direct correlation between the Pco2 and the
[HCO3] (P < 0.001) but no correlation between Pco2 and [P].
However, with higher urinary [HCO] (protocol 3), no further
rise in Pco2 was found. In urine obtained between 10 and 12 AM.
under protocol 1 (without P supplements), the pH was 7.332
0.134, [P] was low (5.29 3.80), [HCO] was high (40.1 16.0
mM/liter), the Pco2 was 74.8 13.2. With somewhat higher [P]
(12.84 7.8 mM/liter) in urine samples obtained between 10 and
12 AM. under protocols 2 and 3, the Pco2 was 89.4 14.0mm
Hg. In all urine samples obtained between 10 and 12 AM. we
found a direct correlation between Pco2 and [P] (P < 0.00 1) but
no correlation between Pco2 and the high [HCO] (50.3 25.3
mM/liter). In all urine samples with both a relatively high [P] (>
10 mM/liter) and [HCO] (> 20 mM/liter), we found a direct cor-
relation between Pco2 and [H] (P < 0.001), but no correlation
between Pco2 and [P]. The pH in these samples was 7.403
0.276, the [HCO] was 68.15 39.43 mM/liter. These results in-
dicate that different factors ([HCO], [P], or [H]) may be critical
determinants of the rise of Pco2 in the urine, with some of these
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factors being subjected to diurnal variation. These factors are to
be considered if the absence of the rise of urinary Pco2 in alkaline
urine is to be used as evidence for the diagnosis of distal renal
tubular acidosis.
Identification of the nuclear antigen involved in mercury-in-
duced glomerulopathy. J. J. Weening, J. Grond, D. v. d. Top,
and P. J. Hoedemaeker, Laboratory of Pathology, University of
Groningen, Groningen, The IVetherlands. In man, exposure to
low doses of anorganic mercury over a prolonged period may
cause a membranous glomerulopathy resulting in proteinuna and
a nephrotic syndrome. A similar glomerulopathy can be induced
by injections of mercury in the PVG/c rat. In these cases, the
deposition of immune complexes along the subepithelial side of
the glomerular basement membrane (GBM) is associated with
the occurrence of antinuclear antibodies in the serum of the in-
jected rats. This antinuclear activity can be eluted from the gb-
merular deposits, suggesting a pathogenetic role of the anti-
nuclear antibody in this glomerulopathy. The character of the
nuclear antigen involved was studied using antinuclear antisera,
purified serum immunoglobulin fractions from these sera, and
eluates from glomeruli of the diseased animals in indirect immu-
nofluorescent techniques. Fixation and acid preincubation of the
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tissue substrate sections (rat liver and kidney) intensified the im-
munofluorescence considerably. The pattern of immuno-
fluorescence was homogenous. Digestion of the substrate by
DNAase and protease eliminated the immunofluorescence,
whereas RNAase did not show this effect. Absorption of anti-
nuclear activity could be obtained with purified nuclei and soni-
cated nuclei, and with extractable nuclear antigen (ENA). No
absorption was obtained with several DNA samples; binding to
double stranded DNA could not be demonstrated in the Crithidia
luciliae; the DNA spot test was negative. Concanavalin A (Con
A) was shown to block the antigenic site completely; administra-
tion of a-methyl-mannoside, the specific inhibitor of Con A, an-
nulled this blocking. Moreover, antinuclear antibodies could be
absorbed with Con A-Sepharose coupled nuclear constituents.
These results indicate that the nuclear antigen involved in the
glomerulopathy described is likely to be a nonhiston chromatin
glycoprotein. Studies on the ultrastructural localization of anor-
ganic mercury have shown that binding of this metal pre-
dominantly occurs to the same nuclear fraction in rat kidney and
liver cells. The mechanism of binding of the antinuclear anti-
bodies to the GBM and a possible parallel with membranous
glomerulopathy associated with systemic lupus erythematosus in
man is intriguing and requires more investigation.
